Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 2
2003 2
2004 1
2005 1
2006 3
2007 5
2008 11
2009 9
2010 5
2011 9
2012 14
2013 26
2014 25
2015 28
2016 24
2017 32
2018 38
2019 55
2020 58
2021 63
2022 92
2023 59
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

505 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hematopoietic and lymphoid cell neoplasm"
Page 1
CAR-T cell therapy for patients with hematological malignancies. A systematic review.
Pasqui DM, Latorraca CDOC, Pacheco RL, Riera R. Pasqui DM, et al. Eur J Haematol. 2022 Dec;109(6):601-618. doi: 10.1111/ejh.13851. Epub 2022 Sep 18. Eur J Haematol. 2022. PMID: 36018500 Review.
Hematological malignancies represent defying clinical conditions, with high levels of morbidity and mortality, particularly considering patients who manifest multiple refractory diseases. Recently, chimeric antigen receptor (CAR)-T cell therapy has emerged as a potential t …
Hematological malignancies represent defying clinical conditions, with high levels of morbidity and mortality, particularly considering pati …
Splenic irradiation for splenomegaly: A systematic review.
Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf PL, Hayes SB, Meyer JE. Zaorsky NG, et al. Cancer Treat Rev. 2017 Feb;53:47-52. doi: 10.1016/j.ctrv.2016.11.016. Epub 2016 Dec 22. Cancer Treat Rev. 2017. PMID: 28063304 Free PMC article. Review.
Splenic irradiation (SI) is a palliative treatment option for symptomatic splenomegaly (i.e. for pain, early satiety, pancytopenia from sequestration) secondary to hematologic malignancies and disorders. The purpose of the current article is to review the literature on SI …
Splenic irradiation (SI) is a palliative treatment option for symptomatic splenomegaly (i.e. for pain, early satiety, pancytopenia from sequ …
Clinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic Review.
Grant SJ, Grimshaw AA, Silberstein J, Murdaugh D, Wildes TM, Rosko AE, Giri S. Grant SJ, et al. Transplant Cell Ther. 2022 Jun;28(6):294-302. doi: 10.1016/j.jtct.2022.03.006. Epub 2022 Mar 11. Transplant Cell Ther. 2022. PMID: 35288347 Free PMC article. Review.
Chimeric antigen receptor (CAR) T cell therapy is a novel therapy for patients with relapsed or refractory hematologic malignancies. ...Here we describe the clinical, biological, and radiological findings associated with ICANS in adults with hematologic malig …
Chimeric antigen receptor (CAR) T cell therapy is a novel therapy for patients with relapsed or refractory hematologic maligna …
Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data.
Zinzi A, Gaio M, Liguori V, Cagnotta C, Paolino D, Paolisso G, Castaldo G, Nicoletti GF, Rossi F, Capuano A, Rafaniello C. Zinzi A, et al. Pharmacol Res. 2023 Apr;190:106742. doi: 10.1016/j.phrs.2023.106742. Epub 2023 Mar 22. Pharmacol Res. 2023. PMID: 36963592 Free article. Review.
Chimeric Antigen Receptor (CAR)-modified T lymphocytes represent one of the most innovative and promising approaches to treating hematologic malignancies. CAR-T cell therapy is currently being used for the treatment of relapsed/refractory (r/r) B-cell maligna …
Chimeric Antigen Receptor (CAR)-modified T lymphocytes represent one of the most innovative and promising approaches to treating hematolo …
Cancer Risk in Hashimoto's Thyroiditis: a Systematic Review and Meta-Analysis.
Hu X, Wang X, Liang Y, Chen X, Zhou S, Fei W, Yang Y, Que H. Hu X, et al. Front Endocrinol (Lausanne). 2022 Jul 12;13:937871. doi: 10.3389/fendo.2022.937871. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35903279 Free PMC article.
Data analysis suggested that patients with Hashimoto's thyroiditis had an increased risk of developing breast cancer, urogenital cancer, digestive organs cancer, hematologic cancer, and a low risk of respiratory cancers. CONCLUSIONS: This systematic review and meta-analysi …
Data analysis suggested that patients with Hashimoto's thyroiditis had an increased risk of developing breast cancer, urogenital cancer, dig …
Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis.
Manothummetha K, Mongkolkaew T, Tovichayathamrong P, Boonyawairote R, Meejun T, Srisurapanont K, Phongkhun K, Sanguankeo A, Torvorapanit P, Moonla C, Plongla R, Kates OS, Avery RK, Nematollahi S, Permpalung N. Manothummetha K, et al. Clin Microbiol Infect. 2023 Oct;29(10):1272-1279. doi: 10.1016/j.cmi.2023.04.021. Epub 2023 Apr 26. Clin Microbiol Infect. 2023. PMID: 37116860 Review.
BACKGROUND: Ribavirin use for respiratory syncytial virus (RSV) infection in patients with haematologic malignancies (HM) and haematopoietic stem cell transplant (HSCT) recipients remains controversial. OBJECTIVES: To summarize the current evidence of ribavirin treatment i …
BACKGROUND: Ribavirin use for respiratory syncytial virus (RSV) infection in patients with haematologic malignancies (HM) and haematopoietic …
Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis.
Grigor EJM, Fergusson D, Kekre N, Montroy J, Atkins H, Seftel MD, Daugaard M, Presseau J, Thavorn K, Hutton B, Holt RA, Lalu MM. Grigor EJM, et al. Transfus Med Rev. 2019 Apr;33(2):98-110. doi: 10.1016/j.tmrv.2019.01.005. Epub 2019 Feb 14. Transfus Med Rev. 2019. PMID: 30948292 Free article.
Promising efficacy results of chimeric antigen receptor (CAR) T-cell therapy have been tempered by safety considerations. Our objective was to comprehensively summarize the efficacy and safety of CAR-T cell therapy in patients with relapsed or refractory hematolo …
Promising efficacy results of chimeric antigen receptor (CAR) T-cell therapy have been tempered by safety considerations. Our objecti …
Aerobic physical exercise for adult patients with haematological malignancies.
Knips L, Bergenthal N, Streckmann F, Monsef I, Elter T, Skoetz N. Knips L, et al. Cochrane Database Syst Rev. 2019 Jan 31;1(1):CD009075. doi: 10.1002/14651858.CD009075.pub3. Cochrane Database Syst Rev. 2019. PMID: 30702150 Free PMC article.
The overall potential risk of bias in the included trials is unclear, due to poor reporting.The majority of participants suffered from acute lymphoblastic leukaemia (ALL), acute myeloid leukaemia (AML), malignant lymphoma and multiple myeloma, and eight trials randomised people r …
The overall potential risk of bias in the included trials is unclear, due to poor reporting.The majority of participants suffered from acute …
505 results